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Abstract
Background: The most frequent genetic cause of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral
sclerosis (ALS) is the expansion of a GGGGCC hexanucleotide repeat in a non-coding region of the chromosome 9
open reading frame 72 (C9orf72) locus. The pathological hallmarks observed in C9orf72 repeat expansion carriers are
the formation of RNA foci and deposition of dipeptide repeat (DPR) proteins derived from repeat associated non-ATG
(RAN) translation. Currently, it is unclear whether formation of RNA foci, DPR translation products, or partial
loss of C9orf72 predominantly drive neurotoxicity in vivo. By using a transgenic approach in zebrafish we address if the
most frequently found DPR in human ALS/FTLD brain, the poly-Gly-Ala (poly-GA) protein, is toxic in vivo.
Method: We generated several transgenic UAS responder lines that express either 80 repeats of GGGGCC alone, or
together with a translation initiation ATG codon forcing the translation of GA80-GFP protein upon crossing to a Gal4
driver. The GGGGCC repeat and GA80 were fused to green fluorescent protein (GFP) lacking a start codon to monitor
protein translation by GFP fluorescence.
Results: Zebrafish transgenic for the GGGGCC repeat lacking an ATG codon showed very mild toxicity in the absence of
poly-GA. However, strong toxicity was induced upon ATG initiated expression of poly-GA, which was rescued by injection
of an antisense morpholino interfering with start codon dependent poly-GA translation. This morpholino only interferes
with GA80-GFP translation without affecting repeat transcription, indicating that the toxicity is derived from GA80-GFP.
Conclusion: These novel transgenic C9orf72 associated repeat zebrafish models demonstrate poly-GA toxicity in zebrafish.
Reduction of poly-GA protein rescues toxicity validating this therapeutic approach to treat C9orf72 repeat expansion
carriers. These novel animal models provide a valuable tool for drug discovery to reduce DPR associated toxicity in
ALS/FTLD patients with C9orf72 repeat expansions.
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Background
Expansion of the GGGGCC hexanucleotide repeat in the
C9orf72 intronic region was recently identified as a cause
for amyotrophic lateral sclerosis (ALS) and frontotem-
poral lobar degeneration (FTLD) [1–3]. This repeat
expansion is observed in around 40% of familial and 7% of
sporadic cases of ALS and 25% of familial and 6% of
sporadic cases of FTLD [4]. Affected patients have
hundreds to several thousands of repeats, while healthy
individuals generally have 2 to 23 repeats [1–3, 5]. The
expanded repeat RNA is transcribed and accumulates in
RNA foci, which have been detected in brain tissue,
lymphoblasts, as well as fibroblasts derived from patients
with the C9orf72 associated repeat expansion [6]. This
long repeat RNA transcript can sequester RNA binding
proteins, including heterogeneous nuclear ribonucleopro-
tein A3 (hnRNPA3), hnRNPH, and nucleolin, and can lead
to mis-regulation of RNA splicing [7–9]. Interestingly,
despite the absence of an ATG start codon, the repeat
* Correspondence: bettina.schmid@dzne.de
1German Center for Neurodegenerative Diseases (DZNE),
Feodor-Lynen-Str.17, 81377 Munich, Germany
4Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Str.17,
81377 Munich, Germany
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ohki et al. Molecular Neurodegeneration  (2017) 12:6 
DOI 10.1186/s13024-016-0146-8
RNA is further subjected to unconventional repeat associ-
ated non-ATG (RAN) translation [7, 9–11] resulting in
dipeptide repeat proteins (DPRs) of Gly-Ala (poly-GA),
Gly-Arg (poly-GR) and Gly-Pro (poly-GP) and additional
Gly-Pro (poly-GP), Pro-Ala (poly-PA) and Pro-Arg (poly-
PR) from the transcribed antisense strand. The DPRs form
cytosolic coaggregates with p62 in the brains of patients
with C9orf72 repeat expansions [12–15] and have been
shown to interfere with RNA metabolism and coaggregate
with other proteins [16–20]. Additionally, interference of
DPRs with nucleocytoplasmic transport has been identi-
fied independently in different model systems by unbiased
genetic screens [21–25].
Three pathomechanisms have been postulated in
C9orf72 repeat expansion carriers, which are not mutually
exclusive and most likely act in combination. First,
haploinsufficiency due to reduced transcript levels of
C9orf72. Second, toxicity of RNA foci by sequestration of
important RNA binding proteins and disturbed RNA
homeostasis. Third, toxicity of RAN translation products.
We set out to generate transgenic zebrafish lines with
expanded GGGGCC repeats and poly-GA as a verte-
brate animal model to address their contribution to
toxicity. We generated two transgenic lines expressing
80 repeats of the GGGGCC sequence (ggggcc80) and
two lines with the translation initiation codon ATG in
front of the 80xGGGGCC repeat sequence driving
expression of poly-GA protein fused to green fluorescent
protein (GA80-GFP). We chose poly-GA since it is the
most abundant DPR species found in patients with
C9orf72 repeat expansions [13, 26]. The transgenic
zebrafish models with 80 repeats reproduced key patho-
logical features, such as RNA foci, however RAN trans-
lation was not detectable. Transgenic zebrafish with 80
repeats of GGGGCC only showed minor toxicity (mild
pericardial edema), which was greatly increased when
we forced expression of poly-GA by 80 GGGGCC
repeats with an ATG translational start codon in the GA
frame (severe pericardial edema). By blocking poly-GA
translation by an antisense approach, we show that the
phenotypes can be partially rescued, demonstrating that
poly-GA is toxic in vivo and that targeting poly-DPRs
might be a useful therapeutic strategy for C9orf72 repeat
expansion carriers.
Results
Generation of a transgenic zebrafish model of C9orf72
repeat expansion disease
We generated several transgenic zebrafish UAS-based
responder lines expressing either 2 or 80 repeats with an
ATG (Tg(UAS:ATG-2xGGGGCC-GFP) and Tg(UAS:ATG-
80xGGGGCC-GFP)) in the GA reading frame as well as 80
GGGGGCC repeats without ATG (Tg(UAS:80xGGGGCC-
GFP)) fused to GFP (Fig. 1a). We generated these lines by
Tol2 mediated transposition into the zebrafish genome
[27]. We confirmed successful germline transmission of the
transgenes by PCR-based genotyping. The 80xGGGGCC
repeat sequence was unstable and changes in repeat length
were frequently observed in the F1 generation (data not
shown). We selected stable transgenic lines with
80xGGGGCC repeats and confirmed the repeat length by
PCR (Fig. 1b). To exclude potential toxicity mediated by
the transgene integration site, we selected 2 independent
lines (a and b) for Tg(UAS:ATG-2xGGGGCC-GFP) and
Tg(UAS:ATG-80xGGGGCC-GFP), which we will refer to
as GA2-GFPa/b and GA80-GFPa/b respectively. Compar-
able mRNA expression levels of the respective transgene
were confirmed by semi-quantitative reverse transcription
PCR (RT-PCR) upon crossing the responder lines to the
gene trap Gal4 driver line SAGFF73A [28]. This line drives
expression of high level of Gal4 ubiquitously at early em-
bryonic stages and was used in all experiments to drive
transgene expression of the respective UAS driver lines. All
transgenic lines showed comparable RNA expression levels
at 4 days post fertilization (dpf) (Fig. 1c). Additionally, we
confirmed the expression of GA80-GFP protein by
immunoblotting at 4 dpf (Fig. 1d). The GA2-GFPa/b larvae
showed 7.2 fold higher GFP protein expression levels com-
pared to the GA80-GFPa/b larvae (mean of line a and b).
This suggests that despite nearly equal mRNA levels, less
poly-GA is translated in the GA80-GFP fish than the GA2-
GFP fish. A poly-GA specific antibody also detected the
GA80-GFP protein (Fig. 1d), but failed to detect GA2-GFP,
most likely because two GA repeats are too short to be rec-
ognized by the antibody.
Tg(UAS:80xGGGGCC-GFP) fish expressing repeat
RNA without a start codon were generated and fish with
a stable length of 80 repeats were selected by PCR
(Fig. 1c). This line will be referred to as ggggcc80-GFP.
Although the expression level of mRNA is similar to
those of GA2-GFP and GA80-GFP expressing fish, poly-
GA peptides derived from RAN translation were not de-
tectable by Western blotting in the ggggcc80-GFP fish at
4 dpf (Fig. 1d). We also failed to detect poly-GR and
poly-GP (data not shown). Thus, if RAN translation
occurs in the ggggcc80-GFP line, it is below the detec-
tion limit of our specific antibodies.
RNA derived from GA80-GFP and ggggcc80-GFP lead to
RNA foci formation
To test if pathological hallmarks of C9orf72 repeat ex-
pansion disease are found in transgenic zebrafish with
an expanded GGGGCC repeat, we analyzed RNA foci
formation at 28 h post fertilization (hpf ). GA80-GFP as
well as ggggcc80-GFP zebrafish showed RNA foci in
spinal cord neurons by in situ hybridization, whereas
wild-type and GA2-GFP zebrafish did not show RNA
foci (Fig. 2a and Additional file 1: Figure S1). We further
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confirmed that the RNA foci are sensitive to RNaseA
but not to DNase treatment, confirming the RNA nature
of the foci (Fig. 2b and Additional file 1 Figure S1).
ggggcc80-GFP expression displays mild toxicity in
zebrafish
We next analyzed ggggcc80-GFP transgenic fish for signs
of toxicity. ggggcc80-GFP larvae showed a pericardial
edema phenotype at 4 dpf. We categorized the phenotypes
based on their severity in three groups: 1. wild-type, 2.
mild edema and 3. severe pericardial edema as shown
in Fig. 2c. Of the ggggcc80-GFP larvae 50.2 ± 13.7%
(mean ± SD) were unaffected, 32.2 ± 8.2% had a mild
pericardial edema and 17.2 ± 11.6% had a severe pericar-
dial edema at 4 dpf (Fig. 2d). The edema phenotype pre-
cluded inflation of the swim bladder, inability to feed
independently, and death during early larval stages. No
abnormal phenotype was detectable in GA2-GFP larvae,
suggesting that the expanded GGGGCC repeat causes the
mild toxicity in the ggggcc80-GFP fish.
GA80-GFP protein expression is highly toxic in zebrafish
Poly-GA has previously been shown to be toxic in
neurons and animal models [23, 29]. Expression of
GA80-GFP protein was detected by diffuse green GFP
expression and as GFP inclusions exclusively in the mus-
culature by 2 and 4 dpf (Fig. 3a), whereas GA2-GFP fish
showed only diffuse green fluorescence. Almost all
GA80-GFPa expressing fish showed a severe pericardial
edema (92.8 ± 2.8%) and only very few fish showed a
mild pericardial edema (7.2 ± 2.8%) at 4 dpf. Similarly,
the second transgenic line GA80-GFP-b had 97.5 ± 2.6%
Fig. 1 Generation of transgenic zebrafish model of C9ORF72 repeat expansion disease. a Schematic representation of Gal4 driver line zebrafish
crossed to a UAS responder transgenic zebrafish to generate embryos that express a transgene under the control of the UAS. Schematic representation of
the responder constructs used for the generation of transgenic zebrafish. b Genotyping by PCR of 1 dpf embryos. pCS2 + 2xGGGGGCC
and pCS2 + 80XGGGGCC constructs were used as standards for GA2-GFP and GA80-GFP in lane 2 and 3. Positions of 2xGGGGCC and 80xGGGGCC repeats
are indicated by arrows. c Semi-quantitative RT-PCR analyses for the wild-type, GA2-GFPa/b, GA80-GFPa/b and ggggcc80-GFP zebrafish.
Note that all transgenic lines showed similar expression level at 4 dpf embryos. d Immunoblotting of wild-type, GA2-GFPa/b, GA80-GFPa/b and
ggggcc80-GFP with antibodies as indicated with embryonic lysates of 4 dpf old embryos
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of the fish with an severe pericardial edema and 2.5 ±
2.6% with an mild pericardial edema at 4 dpf (Fig. 3b).
Additionally, GA80-GFPa/b fish also showed a strongly
reduced circulation of red blood cells in 61.5 ± 9.0% (line
a) and 21.6 ± 3.9% (line b) of the GFP positive embryos at
2 dpf, respectively. In contrast, wild-type, GA2-GFPa/b as
well as ggggcc80-GFP fish did not show any circulation
defect of red blood cells at 2 dpf (Fig. 3c,d), suggesting
that poly-GA toxicity additionally impaired circulation.
The circulation defect did not seem to be mediated by a
heart defect since the GA80-GFPa fish had a normal heart
beat at 2.5 dpf (data not shown). Phenotypic embryos with
a strong edema and lack of circulation died around 5 dpf.
We further examined the length of the spinal motor
neuron axons in GA80-GFPa zebrafish, since C9orf72
repeat expansion carriers can suffer from motor neuron
degeneration. No significant differences of the axonal
length were observed at 28 hpf (Additional file 2: Figure
S2A, B). In addition, there was no apparent difference in
the overall neuronal outgrowth and branching at 2 dpf
(Additional file 3: Figure S3A, B), indicating expression
of neither an expanded GGGGCC repeat nor poly-GA
protein affected neuronal outgrowth. Interestingly, ag-
gregates of GA80-GFP were exclusively found in the
musculature despite ubiquitous GA80-GFP protein ex-
pression in both transgenic GA80-GFP lines at 2 and 4
dpf. Larvae with a severe edema phenotype had more
than twice as many inclusions compared to larvae with a
mild phenotype at 4 dpf (Additional file 4: Figure S4A),
suggesting that these embryos have higher expression
levels, leading to higher toxicity and more inclusions.
The overall structure of the muscle was not affected as
determined by α-actinin staining at 2 dpf (Additional file
4: Figure S4B), suggesting that the GA80-GFP aggregates
themselves are not toxic and that muscle defects are not
the primary cause of toxicity in our zebrafish model.
Previously, we reported that knockout of the two
orthologues of human TDP-43, a key protein in ALS/
FTLD, in zebrafish (tardbp−/−, tardbpl−/−) showed a
circulation phenotype accompanied with mispatterning
Fig. 2 RNA foci formation in transgenic zebrafish. a, b Cy3-labeled in situ probe detected dot-like structures in spinal cord in GA80-GFPa/b and
ggggcc80-GFP zebrafish. b Foci were only detected in GA80-GFP and ggggcc-GFP fish whereas no foci were detected in wild-type and GA2-GFPa/b
fish at 28 hpf. GA80-GFPa zebrafish were treated with RNaseA or DNase. Scale bar 10 μm. c Pericardial edema phenotype observed in ggggcc80-GFP
zebrafish at 4 dpf. Phenotypic features are classified as wild-type, mild edema, and severe edema. d The average percentages of phenotypic fish of the
three different phenotypic classes at 4 dpf are indicated in the bargraph (at least three independent clutches were analyzed with n≥ 14)
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and increased sprout formation of the vasculature [19].
Since C9orf72 repeat expansion carriers show cytoplas-
mic TDP-43 mislocalization and presumably partial
TDP-43 loss of function, we analyzed TDP-43 function
in the repeat expressing fish. We examined vascular pat-
terning in GA80-GFPa zebrafish by crossing them to
Tg(kdrl:HsHRAS-mCherry)s896, a reporter line express-
ing mCherry in all endothelial cells [20]. However, nei-
ther vascular mispatterning nor aberrant sprout
formation as seen in tardbp−/−, tardbpl−/− fish were
detected at 2.5 dpf (Additional file 5: Figure S5A, B), rul-
ing out vascular patterning defects as the primary cause
Fig. 3 Poly-GA protein elicits a toxic phenotype. a In vivo image of GA-GFP polypeptides at 2 and 4 dpf. Genotypes as indicated. No GFP sibling
(GA80-GFP) refers to a sibling from a cross between a Gal4 driver and a UAS GA80-GFP responder fish that is GFP negative, and hence is either nega-
tive for the driver or the responder construct, or both constructs. GFP fluorescent images shown are merged with DIC pictures. Lowest panel is a mag-
nification of the middle panel at 4 dpf. Lateral views of the trunk musculature. Scale bar 20 μm. b A strong pericardial edema phenotype was observed
in GA80-GFPa/b zebrafish at 4 dpf. The average percentages of phenotypic fish of the three different classes are indicated in the bargraph.
c GA80-GFPa/b zebrafish had mostly no circulation at 2 dpf. Red blood cells accumulate due to circulation defects (arrow). d The average percentages of
fish with or without circulation are indicated in the bargraph (at least three independent clutches were analyzed with n ≥14)
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of the circulation phenotype. However, endothelial cells
appeared thinner and less structured in GA80-GFPa lar-
vae (Additional file 5: Figure S5), most likely due to the
lack of perfusion. Reduction of zebrafish Tardbp function
leads to an alternative splicing pattern of the second
ortholgue Tardbpl, referred to as Tardbpl_tv1, which can
fully replace Tardbp function. Impaired Tardbp function
(for example by mislocalization) can therefore be moni-
tored by upregulation of the compensatory Tardbpl_tv1
variant. We analyzed the expression levels of Tardbp as
well as Tardbpl_tv1 by immunoblotting in GA80-GFPa
zebrafish at 2 dpf. Increased levels of Tardbpl_tv1 would
indicate partial loss of Tardbp. However, protein levels
of Tardbp and Tardbpl_tv1 showed no differences in
wild-type and GA80-GFP transgenic fish (Additional file
6: Figure S6), suggesting that the perfusion phenotype is
mediated by a TDP-43 independent mechanism.
Antisense morpholino (AMO) rescues the edema
phenotype in GA80-GFP zebrafish
Antisense morpholinos (AMO) are a useful tool to
suppress the translation of genes of interest. Here, we
designed AMOs targeting GAL4 as well as the ATG
start codon of the GA80-GFP transgene (Fig. 4a) to
further substantiate the correlation of GA80-GFP pro-
tein levels and toxicity. Injection of the AMO targeting
GAL4 into the fertilized embryos in GA80-GFPa
efficiently blocked translation of the transcriptional
activator Gal4 and thereby efficiently reduced GA80-
GFP protein expression at 2 dpf (Fig. 4b). Although
control AMO injected transgenic zebrafish showed
mostly the severe edema phenotype (95.8 ± 3.9%) and
very few mild edema phenotypes (4.2 ± 3.9%), GAL4
AMO injected fish showed only few severe (4.8 ±
8.2%) and mild (8.6 ± 8.3%) and mostly unaffected
zebrafish (86.7 ± 8.3%), indicating that AMO mediated
GAL4 inhibition rescued the pericardial edema
phenotype at 4 dpf (Fig. 4b).
To further address if toxicity is mediated by the expres-
sion of GA80-GFP protein we designed AMO targeting
ATG start codon upstream of the GGGGCC repeat (ATG
AMO) and aimed at reverting the phenotype by blocking
translation of the poly-GA protein in the GA80-GFPa lar-
vae. Upon injection of ATG AMO, GA80-GFP protein ex-
pression was severely reduced, as determined by
immunoblot at 2 dpf (Fig. 4c). In addition, ATG targeting
AMO reduced the severe pericardial edema phenotype in
GA80-GFP expressing zebrafish demonstrating that poly-
GA protein is a toxic species in vivo at 4 dpf (Fig. 4c.). We
next examined the expression level of mRNA as well as
RNA foci formation upon ATG targeting AMO injection,
since they are blocking translation without changing the
mRNA. mRNA expression levels analyzed at 2 dpf by
semi-quantitative RT-PCR were unaffected in phenotypic
fish upon ATG AMO injection and RNA foci were still
detectable (Fig. 4d, e, Additional file 1 Figure S1) indicat-
ing that poly-GA was toxic in zebrafish and that the
phenotypic rescue is mediated by reduction of GA80-GFP
protein levels.
Discussion
Expansion of a GGGGCC repeat in a non-coding region of
C9orf72 is the most common cause of ALS/FTLD. Re-
cently, RAN translation from the sense and antisense
GGGGCC repeat transcript was observed in C9orf72 repeat
expansion carriers generating 5 different DPR species
(poly-GA, −GR, −GP, −PA and -PR) [12–14, 30]. These
DPRs coaggregate with p62 and form the characteristic star
shaped inclusions in C9orf72 repeat expansion carriers [13].
The relative contribution of RNA and DPR toxicity is
still under debate since many conflicting results have
been obtained in a variety of different model systems
(reviewed in [31]). The GGGGCC repeat RNA forms
foci in cells, animal models and patients and has been
shown to be able to induce neuronal cell death and to
sequester RNA binding proteins [8, 15, 20, 32]. However,
there is only a weak correlation between RNA foci and
neurodegeneration in patients [33–35]. In zebrafish
RNA injection of 8x, 38x, and 72x GGGGCC repeats
has been shown to cause RNA foci and cell death by
apoptosis in a repeat length dependent manner [9]. This
study did not report on RAN translation products upon
repeat RNA injections in zebrafish. In line with these
studies we observe RNA foci in two independent trans-
genic ggggcc80-GFP lines and RNA toxicity. In the
ggggcc80-GFP fish we were not able to detect GA, GP,
and GR species, most likely due to the relatively short
repeat length or inefficient or even lack of RAN transla-
tion in early zebrafish that preclude detection of DPR
species by Western blotting. This is in contrast to fly
and mouse models in which repeat expression leads to
DPR translation in the absence of a start codon [18, 20].
Whether the mild toxic effects seen in ggggcc80-GFP
fish is due to RNA toxicity or low level DPRs remains to
be determined. To further address DPR toxicity we fo-
cused on poly-GA since it is the most abundant species
found in C9orf72 repeat carriers and induced the neur-
onal cell death in primary cultured cell model as well as
in animal models [16–18, 20]. We generated several
transgenic zebrafish lines and demonstrated that poly-
GA is toxic in zebrafish. In primary neurons poly-GA
toxicity has been attributed to sequestration of Unc119
(a trafficking factor for myristylated proteins), interfer-
ence with the ubiquitin proteasome system, and endo-
plasmic reticulum stress [16, 17]. Recently, poly-GR and
poly-PR were shown to be the most toxic DPR species
in Drosophila [18, 36]. Moreover, the arginine-rich DPR
species are also toxic in primary neurons, potentially
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affecting RNA synthesis [18, 19]. Interestingly, DPRs
interfere with nucleocytoplasmic shuttling in Drosophila,
cells, and yeast [21, 22, 24, 25]. Two independently gen-
erated BAC transgenic mouse models recapitulate
C9orf72 repeat associated pathology, however they lack
neurodegeneration [34, 35]. In contrast, another BAC
transgenic mouse model shows neurodegeneration and
TDP-43 pathology [37]. Expression of high levels of
C9orf72 repeats by adeno associated virus in mouse
brain also generate neurodegeneration and TDP-43
Fig. 4 Antisense morpholino rescued the toxic edema phenotype. a Representation of process of intervention for each morpholino during the
generation of GA80-GFP protein in vivo. b GAL4 targeting AMO efficiently blocked Gal4 translation at 2 dpf shown by immunoblotting (upper panel).
Quantification of the pericardial edema phenotype observed in GA80-GFP with injection of ctrl AMO or GAL4 targeting AMO at 4 dpf are shown as a
bar graph (lower panel) (p < 0,001, 3 independent experiments with 3 clutches n≥ 6 are shown, unpaired t test). c ATG targeting morpholino efficiently
inhibited the ATG dependent translation of poly-GA at 2 dpf (upper panel). Quantification of the pericardial edema phenotype observed in GA80-GFP
upon injection of ctrl AMO or ATG targeting AMO at 4 dpf shown as a bar graph (lower panel) (p < 0,005, 3 independent experiments with 3 clutches
n ≥ 19 are shown, unpaired t test). d Semi-quantitative RT-PCR analyses of injected embryos at 2 dpf. e RNA foci formation was not
affected upon injection with ctrl AMO or ATG AMO at 2 dpf. Scale bar 10 μm
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pathology [20]. These differences might reflect that suffi-
ciently high expression levels are required to induce
neurodegeneration. It remains unclear which DPR pro-
teins contribute to ALS/FTLD pathogenesis in patients
under physiological conditions. There is currently little
evidence for a regional correlation of DPR aggregates in
humans and neurodegeneration [38]. These animal
models will be valuable tools to further dissect the rela-
tive contribution and synergistic effects of repeat RNA
and DPRs to toxicity.
GA80-GFP fish showed a circulation defect at 2 dpf
and a severe pericardial edema phenotype at 4 dpf.
Interestingly, double knockout zebrafish (tardbp−/−,
tardbpl−/−) also showed circulation defects at 2 dpf and
vascular mispatterning, resulting in a pericardial edema
phenotype reminiscent of the GGGGCC repeat induced
phenotype [39]. Considering that partial loss of TDP-43
function could be linked to the pathogenesis of ALS/
FTLD-TDP-43, including C9orf72 repeat expansion
carriers [40], we analyzed expression of Tardbp and
Tardbpl_tv1 in GA80-GFP fish. However, no apparent
changes in Tardbp and Tardbpl_tv1 protein level were
observed upon transgene expression, indicating that nei-
ther RNA foci nor poly-GA lead to a loss of TDP-43
function in our zebrafish model. We speculate that po-
tentially a common downstream pathway is affected in
double knockout zebrafish (tardbp−/−, tardbpl−/−) and
GA80-GFP zebrafish, resulting in a similar circulation
defect. However, since pericardial edemas are a common
phenotype, which can be caused by a variety of defects,
we cannot exclude the possibility that these similar phe-
notypes have distinct causes. Unfortunately, the larval le-
thality precludes analysis of possible neurodegenerative
phenotypes of the repeat expressing transgenic zebrafish
during adulthood.
GA80-GFP leads to inclusion formation which was re-
stricted to the musculature. Why the musculature was
more prone to form inclusions in our model remains
speculative. This might be due to higher expression
levels of the GA80-GFP protein or driven by cell type
specific other coaggregating proteins. There was no
correlation of cell death and poly-GA aggregation in
zebrafish, since we did not observe any degeneration of
muscle cells. Interestingly, there is also no clear correl-
ation between DPR aggregate formation and neuronal
loss in C9orf72 repeat expansion patients, raising the
possibility that the aggregates themselves are not the
toxic DPR species [26, 38, 41].
Conclusion
We developed a novel vertebrate animal model for C9orf72
repeat expansion pathomechanisms and demonstrated
that the DPR poly-GA is toxic in vivo. Selective inhibition
of poly-GA production by antisense oligonucleotides
decreased toxicity. These findings indicate that intervention
with DPR expression might be an effective therapeutic
strategy for patients with C9orf72 repeat expansions.
Methods
Zebrafish
Zebrafish embryos were kept at 28.5 °C and staged as
previously described [35]. AB and TLF were used as the
wild-type strains. All experiments were performed in
accordance with animal protection standard of Ludwig
Maximilians University Munich and approved by the
government of upper Bavaria (Regierung von Oberbayern,
Munich, Germany).
Antibodies
Anti-tubulin (Sigma, T6199), anti-GFP (Clontech,
632377), anti-acetylated tubulin (Sigma, T6793), anti-
Tardbp (clone 4A12 [19]), anti-Tardbpl_tv1 (clone 16C8
[19]), anti-znp-1 (DSHB), anti-α-actinin (Sigma, A7811),
anti-GA (clone 5 F2 [16]), anti-GR (clone 5A2 [9]), anti-
mouse IgG, HRP conj. (Promega, W4021), anti-rabbit
IgG, HRP conj. (Promega, W4011), Alexa Fluor anti-
bodies (Invitrogen).
Plasmid construction and generation of transgenic
zebrafish
For the construction of the GA2-GFP and GA80-GFP
plasmids, a Kozak sequence (GCCGCCACC) was inserted
3′ of the ATG.
For the generation of the GA80-GFP and ggggcc80-
GFP plasmids were constructed as described in
Additional file 7: Figure S7. pCS2 + eGFP plasmid [13]
was PCR amplified by Phusion high fidelity polymerase
(New England Biolabs) using the following primers:
GA80-GFP
A: pCS2-f1: 5′-ggccgcaGGTGGCGGAGGTGGCGTG
AGCAAGGGCGAGGAGC-3′
pCS2-r1: 5′-gCATGGTGGCGGCCTTGGAT
CCGGAATTCGAATCGATGGGATCCTGCA-3′
B: pCS2-f2: 5′- gcaGGTGGCGGAGGTGGCGTGAG
CAAGGGCGAGGAGC-3′
pCS2-r2: 5′- tagCAT
GGTGGCGGCCTTGGATCCGGAATTCGAATCG
ATGGGATCCTGCA-3′
ggggcc80xRNA
A’: pCS2-f1: 5′- ggccgcaGGTGGCGGAGGTGGCGT
GAGCAAGGGCGAGGAGC-3′
pCS2-r3: 5′- gGGTGGCGGCCTTGGATCCGGA
ATTCGAATCGATGGGATCCTGCA-3′
B’ pCS2-f2: 5′- gcaGGTGGCGGAGGTGGC
GTGAGCAAGGGCGAGGAGC-3′
pCS2-r2: 5′- tagCATGGTGGCGGCCTTGGATC
CGGAATTCGAATCGATGGGATCCTGCA-3′
Ohki et al. Molecular Neurodegeneration  (2017) 12:6 Page 8 of 11
After purification of the PCR products generated by
A/B or A’/B’, the PCR products were co-incubated at fol-
lowing cycles (94 °C 2 min, 94 °C 30 s, 55 °C 30 s, 72 °C
2 min, 72 °C 10 min, 10 °C 10 min) to produce sticky
end fragments digested by NotI/BfaI (New England Bio-
labs), like for circular plasmid generation. To prepare
the gggggcc80-GFP plasmid for the generation of trans-
genic fish, the pEF-80xGGGGCC plasmid [9] was
digested by BamHI and PmeI (New England Biolabs).
Subsequently, the 80xGGGGCC fragment was purified
and digested by BfaI and NotI. The fragment was then
ligated to a PCR amplified pCS2+ plasmid vector
backbone.
The pCS2 + ATG-80xGGGGCC-GFP and pCS2 +
80xGGGGCC plasmids were digested by StyI (New Eng-
land Biolabs) and HpaI (New England Biolabs) and
cloned into pT2KXIGdeltaIN plasmid (a gift from K.
Kawakami, National Institute of Genetics, Shizuoka,
Japan) to generate transgenic zebrafish by TOL2 medi-
ated transposition. Our pT2KXIGdeltaIN plasmid
harbored one point mutation in the UAS region that
generated a novel StyI recognition site. We therefore
had to reintroduce the StyI- StyI digested fragment that
was previously lost during the cloning procedure into
the pT2 + ATG-80xGGGGCC-GFP/+80xGGGGCC
plasmids.
To generate the ATG-2xGGGGCC-GFP plasmid, the
primer (ATG-short2:’- AAAAGATCCAAGGCCGCCA
CCATGCTAGGGGCCGGGGCCGGGGCTCTCAAAC
T-3′), which includes 2xGGGGCC and a T3 primer
were used for amplification of the pCS2 + eGFP plasmid
backbone [13]. Subsequently, the PCR product as well as
pCS2 + ATG-80xGGGGCC-GFP were digested by StyI
and HpaI and ligated to each other. The pT2 + ATG-
2XGGGGCC-GFP plasmid was generated accordingly.
To generate the transgenic fish, 10 ng/μl of the corre-
sponding plasmid and 100 ng/μl transposase mRNA
were co-injected into 1 cell stage AB embryos.
GA2-GFP and GA80-GFP run at a higher molecular
weight than the calculated 31,3 and 41,3 kDa (including
the 33aa linker sequences) potentially due to posttransla-
tional modifications. GFP coding sequence without a
start codon was used.
Genotyping the repeat length by PCR
To extract genomic DNA from zebrafish embryos, Pro-
teinase K (Roche) treatment (170 μg/ml, overnight) was
performed at 65 °C. Subsequently, Proteinase K was
inactivated at 95 °C for 10 min. To amplify the trans-
gene, GFP specific primers were used for genotyping
(GFP-3f: 5′- GTGGTGCCCATCCTGGTCGAGCT-3′
and GFP-3r: 5′- AGATCTGAGTCCGGACTTGTAC
AG-3′).
To confirm the repeat length, Expand Long Template
PCR System (Roche) was used with slight modifications:
98 °C 10 min, 97 °C 35 s, 55 °C 2min20s, 68 °C 2min20s,
68 °C 10 min, 55 °C 5 min, 50 °C 5 min, 10 °C. Steps
from 2 to 4 were repeated in 49 cycles. [36]. 80rep-1f:
5′-CTAGAGGGTATATAATGGATC-3′ and 80rep-r2:
5′-CTGTGCTGGATATCTGCAGAATT-3′ were used
for PCR.
Whole mount fluorescent in situ hybridization and motor
axonal length measurement
Zebrafish embryos (28 hpf) were fixed in 4% paraformal-
dehyde (PFA) overnight. Protocol modified from Thisse et
al. [42]. The embryo was gradually transferred into phos-
phate buffered saline Tween-20 (PBST), PBST with 30%
methanol (MeOH), PBST with 60% MeOH and finally
100% MeOH and kept at −20 °C overnight. Before Pro-
teinase K treatment, embryos were transferred into PBST
with 60% MeOH, PBST with 30% MeOH and PBST. After
Proteinase K digestion, re-fixation of embryos was per-
formed by PFA for 15 min at room temperature. After
washing with PBST for 5 × 10 min, embryos were pre-
incubated with hybridization buffer (HYB+) for 1 h at 65 °
C. The Cy3(GGCCCC)4 probe was synthesized by IDT
(Integrated DNA Technologies) as previously described
[2] and diluted into 10 ng/μl in HYB+ solution. Embryos
were hybridized overnight at 65 °C. Afterwards, they were
washed in HYB- for 3 × 30 min, 2 × saline sodium citrate
with 0.1% Tween20 (SSCT) for 2 × 15 min, 0.2 × SSCT for
3 × 30 min, PBST 3 × 30 min at 65 °C. After 4,6-diamidin-
2-phenylindol (DAPI) staining, embryos were mounted in
1.5% agarose.
DNaseI (Qiagen) or RNaseA (Thermo scientific) treat-
ment of the embryos was performed after Proteinase K
treatment, by incubation with the respective enzyme in
PBST for 1.5 h at 37 °C prior in situ hybridization.
Measurement of axonal motor neuron axon length
was previously described [19].
Semi-quantitative RT-PCR
The RNeasy kit (Qiagen) was used with on column
DNaseI treatment for total RNA isolation. cDNA
synthesis was performed with M-MLV reverse tran-
scriptase (Invitrogen) and Random Primer Mix (NEB),
followed by a RNaseH (Invitrogen) digest as previ-
ously described [16].
Antisense morpholino (AMO)
Sequences of AMO used in this study:
Control AMO (ctrl AMO) (CCTCTTACCTCAGTTA
CAATTTATA), GAL4 targeting AMO (Gal4 AMO)
(GTTCGATAGAAGACAGTAGCTTCAT) [37], and ATG
targeting AMO (ATG AMO) (CCCCTAGCATGGTGG
CGGCCTT) were all obtained from Genetools. AMOs
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were injected into fertilized embryos according to the man-
ufacturer’s instructions. The Gal4 AMO and the ATG
AMO were used at 125 μM.
Western blotting and immunohistochemistry
A standard protocol was used as previously described
[16]. To stain the anti-α-actinin or anti-acetylated tubu-
lin, in vivo imaging for mCherry expression to analyze
the vasculature, embryos at 2 dpf were fixed by 4% PFA.
Microscopy
Images were taken with a Cell Observer CSU-X1
(Yokogawa) Spinning Disk (Zeiss), AxioCam MRm (Zeiss)
and Evolve 512 (Photometrics) or confocal microscope
LSM710 (Zeiss). Brightness and contrast were adjusted
using Zen blue or gray (Zeiss) and ImageJ. For in vivo im-
aging of GFP fluorescence, dechorionated zebrafish were
incubated with Tricaine (3-amino benzoic acidethylester)
(Sigma) for immobilization. Subsequently, zebrafish were
mounted in the Metaphor (low melting temperature)
agarose (LONZA).
Additional files
Additional file 1: Figure S1. RNA foci formation overview. Embryos of
the indicated genotypes stained with a Cy3-labeled probe to visualize
RNA foci formation by in situ hybridization. Between 13–33 cells per field
of view showed RNA foci in the GA80-GFP larvae. All images were taken
without DAPI fluorescence. Scale bar 10 μm. (PDF 2702 kb)
Additional file 2: Figure S2. Spinal motor neuron axonal outgrowth is
not affected. (A) Spinal motor neuron axon of GA80-GFP fish (Gal4 driver
+ UAS:ATG-80xGGGGCC-GFP responder) and the GFP negative siblings
(Gal4 driver or UAS:ATG-80xGGGGCC-GFP alone, or wild-type) at 28 hpf.
(B) Length of outgrowing spinal motor neuron axons measured from the
exit point of the spinal cord to the tip of the growth cone in the 5 so-
mites anterior of the end of the yolk expansion at 28 hpf (indicated by
the numbers 1–5). Embryos are sorted by the genotypes wild-type, driver,
responder, and driver + responder. Statistical analyses was performed in
indicated genotypes. Scale bar 20 μm. Mean ± SD. (PDF 4905 kb)
Additional file 3: Figure S3. Overall neuronal outgrowth is not
affected. Overall neuronal outgrowth was analyzed in embryos stained
with an antibody against acetylated tubulin at 2 dpf. Siblings of GA80-
GFPa zebrafish expressing GFP (A) or not expressing GFP (B). Scale bar
100 μm. (PDF 6302 kb)
Additional file 4: Figure S4. Muscle patterning is not affected. (A)
Quantification of GFP inclusions in GA80-GFPa and GA80-GFPb larvae
subdivided into mild and strong edema phenotypes at 4 dpf. (n = 4 per
subgroup, mean ± SD). Amount of inclusions from GA80-GFP line a and b
with mild and strong phenotypes were not significantly different (paired
t-test). Inclusions were exclusively detected in the musculature in both
lines. (B) The overall structure of the muscle was analyzed by α-actinin
staining at 2 dpf in a GFP negative GA80-GFP embryo and (B) GFP
positive sibling. Scale bar 20 μm. (PDF 3472 kb)
Additional file 5: Figure S5. Vascular patterning is not affected. The
vasculature was analyzed by incrossing with Tg(kdrl:HsHRAS-mCherry)s896
into the GA80-GFP expressing lines. mCherry expressed from the
Tg(kdrl:HsHRAS-mCherry)s896 transgene is shown in Ga80-GFP-a transgenic
zebrafish not expressing GFP (A) and siblings expressing GFP (B) at 2.5 dpf.
Scale bar 20 μm. (PDF 4003 kb)
Additional file 6: Figure S6. Tardbp function is not impaired in repeat
expressing fish. (A) GA80-GFPa zebrafish expressing GFP and (B) siblings
not expressing GFP. Western blot analysis of 2 dpf old embryos with antibodies
as indicated. Tardbp/Tardbpl_tv1 bands indicated by arrow heads.
(PDF 3086 kb)
Additional file 7: Figure S7. Construction of repeat expressing plasmid
in zebrafish. A representative scheme to generate the 80xggggcc repeat
containing plasmid. (PDF 1457 kb)
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